Dr. Randal Bruce Macurak , MD
Internal Medicine - Gastroenterology • Dallas, TX
3430 W. Wheatland Road, Charlton I Pob, Suite 109
Dallas, TX 75237
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Randal Macurak is listed in NPPES under Internal Medicine - Gastroenterology.
-
NPI assigned on March 21, 2006; this date does not establish years in practice.
-
Published CMS data list 571 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 226 service units.
- 99214 — Established patient outpatient office visit: 68 service units.
- 99204 — New patient outpatient office visit: 61 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 716 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Omeprazole — 150 prescription fills, including refills.
- Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg) — 126 prescription fills, including refills.
- Pantoprazole Sodium — 112 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 17 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 70% of clinicians listed under Internal Medicine - Gastroenterology in Dallas, TX (2024, 117 clinicians with data). Median for this group: 288. Middle half: 129 to 595.
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine - Gastroenterology in Texas (2024, 1,062 clinicians with data). Median for this group: 547. Middle half: 274 to 898.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 573 in 2020 to 571 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
3430 W. Wheatland Road
Charlton I Pob, Suite 109
Dallas, TX 75237
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Texas Digestive Disease Consultants, Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Texas Medical Branch At Galveston
1976
What Public CMS Data Show
Internal Medicine - Gastroenterology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
300 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $68,129 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $52,692 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,399 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$729,588 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $673.91 across 31 records.
By nature of payment
- Food and Beverage: $664.26 across 30 records.
- Education: $9.65 across 1 record.
Reporting-company totals (3 largest of 10)
- ABBVIE INC.: $274.08 across 17 records.
- Ipsen Biopharmaceuticals, Inc: $180.65 across 3 records.
- Salix Pharmaceuticals, a division of Bausch Health US, LLC: $43.74 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
50 years (graduated 1976)
CMS Doctors and Clinicians data list 1976 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Macurak has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Macurak as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Dallas and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 70% of clinicians listed under Internal Medicine - Gastroenterology in Dallas, TX (2024, 117 clinicians with data). Median for this group: 288. Middle half: 129 to 595.
Close to the middle for clinicians listed under Internal Medicine - Gastroenterology in Texas (2024, 1,062 clinicians with data). Median for this group: 547. Middle half: 274 to 898.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Gastroenterology in Dallas, TX (2024, 117 clinicians with data). Median for this group: $37,059. Middle half: $16,895 to $68,129.
Close to the middle for clinicians listed under Internal Medicine - Gastroenterology in Texas (2024, 1,062 clinicians with data). Median for this group: $67,665. Middle half: $33,824 to $110,960.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Internal Medicine - Gastroenterology in Dallas, TX (2024, 117 clinicians with data). Median for this group: $29,345. Middle half: $12,700 to $55,083.
Close to the middle for clinicians listed under Internal Medicine - Gastroenterology in Texas (2024, 1,062 clinicians with data). Median for this group: $52,189. Middle half: $25,629 to $85,474.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Internal Medicine - Gastroenterology in Dallas, TX (2024, 113 clinicians with data). Median for this group: 400. Middle half: 95 to 799.
Close to the middle for clinicians listed under Internal Medicine - Gastroenterology in Texas (2024, 1,099 clinicians with data). Median for this group: 605. Middle half: 194 to 1,148.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Gastroenterology in Dallas, TX (2024, 113 clinicians with data). Median for this group: $47,398. Middle half: $4,662 to $158,518.
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Gastroenterology in Texas (2024, 1,099 clinicians with data). Median for this group: $88,602. Middle half: $16,242 to $268,690.
168 active clinicians are listed under Internal Medicine - Gastroenterology with a practice address in Dallas, TX (1,478 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Dallas
45.2% of these 168 clinicians have the CMS telehealth indicator.
79.8% of these 168 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services varied from year to year: 573 in 2020 and 571 in 2024.
- 2020: 573
- 2021: 741
- 2022: 625
- 2023: 621
- 2024: 571
-
Medicare-allowed amount
Medicare-allowed amount stayed about the same: $71,551 in 2020 and $68,129 in 2024.
- 2020: $71,551
- 2021: $87,851
- 2022: $76,572
- 2023: $72,463
- 2024: $68,129
-
Paid by Medicare
Paid by Medicare varied from year to year: $52,072 in 2020 and $52,692 in 2024.
- 2020: $52,072
- 2021: $68,061
- 2022: $60,520
- 2023: $56,250
- 2024: $52,692
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 97% from 364 in 2020 to 716 in 2024.
- 2020: 364
- 2021: 436
- 2022: 402
- 2023: 582
- 2024: 716
-
30-day fills
30-day fills increased 113% from 658 in 2020 to 1,399 in 2024.
- 2020: 658
- 2021: 783
- 2022: 719
- 2023: 1,046
- 2024: 1,399
-
Part D drug cost
Part D drug cost increased 1162% from $57,798 in 2020 to $729,588 in 2024.
- 2020: $57,798
- 2021: $206,727
- 2022: $822,426
- 2023: $827,821
- 2024: $729,588
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 39% from $1,109.73 in 2021 to $673.91 in 2025.
- 2021: $1,109.73
- 2022: $1,159.87
- 2023: $675.13
- 2024: $783.41
- 2025: $673.91
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 31 records totaling $673.91.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
IQIRVO | General | $150.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LINZESS | General | $30.45 |
| Intra-Sana Laboratories |
Food and Beverage
In-kind items and services
|
RELTONE 200 MG | General | $28.14 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LINZESS | General | $27.63 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $25.49 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $25.40 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
OMVOH | General | $25.39 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $25.14 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $24.43 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $21.65 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Food and Beverage
In-kind items and services
|
ENTYVIO | General | $20.54 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VELSIPITY | General | $20.05 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $19.31 |
| Celltrion USA Inc. |
Food and Beverage
In-kind items and services
|
VEGZELMA | General | $18.03 |
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
IQIRVO | General | $17.85 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.67 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $17.45 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VELSIPITY | General | $16.87 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $16.50 |
| Celltrion USA Inc. |
Food and Beverage
In-kind items and services
|
VEGZELMA | General | $15.68 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $14.35 |
| Sebela Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
SUFLAVE | General | $14.24 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VIBERZI | General | $13.12 |
| Ipsen Biopharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
IQIRVO | General | $12.80 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $12.30 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
226 | 133 | $148.00 | $88.54 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
68 | 60 | $217.00 | $125.88 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
61 | 61 | $332.00 | $162.60 |
|
45380
Biopsy of large bowel using a flexible endoscope
|
44 | 44 | $847.00 | $156.01 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
36 | 33 | $100.00 | $55.59 |
|
43239
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope
|
33 | 33 | $680.00 | $94.04 |
|
G0105
Colorectal cancer screening; colonoscopy on individual at high risk
|
28 | 28 | $778.00 | $176.04 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
21 | 21 | $219.00 | $109.46 |
|
G0121
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk
|
21 | 21 | $781.00 | $176.26 |
|
45385
Removal of polyps or growths of large bowel using an endoscope with mechanical snare
|
19 | 18 | $1067.00 | $224.31 |
|
45378
Diagnostic exam of large bowel using a flexible endoscope
|
14 | 13 | $781.00 | $177.16 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Omeprazole | Omeprazole | 150 | 11,250 | $2,445.63 | 54 |
| Peg 3350-Electrolyte | Sodium Chloride/Nahco3/Kcl/Peg | 126 | 229 | $2,895.89 | 121 |
| Pantoprazole Sodium | Pantoprazole Sodium | 112 | 9,070 | $1,408.00 | 36 |
| Amitriptyline Hcl | Amitriptyline Hcl | 70 | 3,900 | $850.63 | 18 |
| Dicyclomine Hcl | Dicyclomine Hcl | 38 | 2,300 | $871.35 | 16 |
| Linzess | Linaclotide | 38 | 2,160 | $38,112.56 | 16 |
| Famotidine | Famotidine | 33 | 2,250 | $519.50 | — |
| Ondansetron Odt | Ondansetron | 21 | 339 | $506.53 | — |
| Cholestyramine | Cholestyramine (With Sugar) | 19 | 1,154 | $1,293.65 | — |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | 1,620 | $567.47 | — |
| Suflave | Peg 3350/Sod Sulf,chlr/Pot/Mag | 16 | 49 | $2,002.68 | 16 |
| Creon | Lipase/Protease/Amylase | 15 | 693 | $69,905.50 | — |
| Stelara | Ustekinumab | 13 | 364 | $418,559.83 | — |
| Mesalamine | Mesalamine | 13 | 1,034 | $2,960.50 | — |
| Sucraid | Sacrosidase | 12 | 360 | $168,833.16 | — |
| Colestipol Hcl | Colestipol Hcl | 11 | 432 | $525.48 | — |
| Viberzi | Eluxadoline | 11 | 330 | $17,329.18 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-05-03NUCC Taxonomy Code: 207RG0100X
An internist who specializes in diagnosis and treatment of diseases of the digestive organs including the stomach, bowels, liver and gallbladder. This specialist treats conditions such as abdominal pain, ulcers, diarrhea, cancer and jaundice and performs complex diagnostic and therapeutic procedures using endoscopes to visualize internal organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GASTROENTEROLOGY
I20101103001242
TX
1355341108
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Texas Digestive Disease Consultants, Pllc
3430 W Wheatland Rd, Dallas, TX 752373447
Phone: 9727801111
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.)
Physician Assistant
Physician Assistant (Certified)
Orthopaedic Surgery
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant
Internal Medicine - Interventional Cardiology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 8267 ELMBROOK DR STE 200, DALLAS, TX 752474078 (Tel: 2144242200)
Recorded as RANDAL MACURAK, M.D.
Registered at 7610 N STEMMONS FWY STE 600, DALLAS, TX 752474228 (Tel: 2146895960)
NPI status registered as active in NPPES database
Registered at 3430 W. WHEATLAND ROAD, CHARLTON I POB, SUITE 109, DALLAS, TX 75237 (Tel: 9722961983)
Registered at 7610 STEMMONS FWY, SUITE 500, DALLAS, TX 752474231 (Tel: 2146895960)
Recorded as RANDALL MACURAK, M.D.
Internal Medicine (license number reported to NPPES: TX E6132)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Gastroenterology Specialists in Dallas
- Dr. Robert Anderson, MD
- Dr. Savreet Sarkaria, MD
- Dr. Chenlu Tian, MD
- Dr. Themistocles Dassopoulos, MD
- Dr. Vani Konda, MD
- Dr. Rushikesh Shah, MD
Mailing Address
8267 Elmbrook Dr Ste 200
Dallas, TX 752474078
Phone: 2144242200